NTRS vs RNXT · P/E 18, rev $8.09B vs rev $266.0K
Northern Trust Corporation (NTRS) versus RenovoRx Inc (RNXT) — a side-by-side from cached financials, not a winner call.
Northern Trust Corporation (NTRS) is a asset management company listed on US.
RenovoRx Inc (RNXT) is a biotechnology company listed on US.
Latest reported NTRS revenue for 2025-12-31 was $8.09B. Net income was $1.74B. Revenue was down 2.5% from 2024-12-31 to 2025-12-31. NTRS currently screens at market cap $32.02B and trailing P/E 18.1.
Latest reported RNXT revenue for 2025-09-30 was $266.0K. Net income was -$2.9M. Revenue was down 37.0% from 2025-06-30 to 2025-09-30. RNXT currently screens at market cap $47.0M.
NTRS currently screens at market cap $32.02B and trailing P/E 18.1. RNXT currently screens at market cap $47.0M.
Not investment advice. Open the NTRS and RNXT stock pages for the full models.
Not investment advice.